▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2517 by analyst upside · 2026-11-13
ALKS
Alkermes plc
Healthcare · Market Cap $8B · P/E 0x
ANALYST PRICE TARGET
+22.9%
implied upside to consensus target
Current Price $46.98
Consensus Target $57.74
Bull Target $83.0
Bear Target $38.0
Analysts Covering 19
ANALYST CONSENSUS - BUY
Strong Buy
3
Buy
11
Hold
4
Sell
1
52-Week Low $27.0
52-Week High $55.67
YTD Return +66.2%
FUNDAMENTALS
Market Cap $8B
P/E Ratio (TTM) N/A
Forward P/E 34.7x
EPS (TTM) $-0.01
PEG Ratio 1.96
Dividend Yield N/A
Revenue (TTM) $1.8B
Profit Margin -0.0%
52-WEEK RANGE
52-Week Low $27.0
52-Week High $55.67
Current Price $46.98
Bear Target $38.0
Bull Target $83.0
● Now $46.98 ● Target $57.74
TRADING DATA
Avg Volume 1.9M
YTD Return +66.2%
Analyst Count 19
Consensus Buy
Upside to Target +22.9%
Last Updated 2026-11-13

ANALYST SUMMARY

Alkermes plc (ALKS) is currently trading at $46.98 with a Wall Street consensus price target of $57.74, implying potential upside of 22.9% over the next 12 months. 19 analysts currently cover ALKS, with a consensus rating of Buy - 74% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $83.0, while the most cautious has a target of $38.0.

ALKS operates in the Healthcare sector with a market capitalisation of $8B. The stock is up 66.2% year-to-date and is currently trading near the upper end of its 52-week range of $27.0 – $55.67.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

CHE +12.1%
Chemed Corporation
$7B · P/E 26.4x · Buy
GMED +29.2%
Globus Medical, Inc.
$10B · P/E 17.8x · Buy
HSIC +12.1%
Henry Schein, Inc.
$10B · P/E 23.6x · Buy
UHS +0.7%
Universal Health Services, Inc.
$11B · P/E 8.1x · Hold
PACS +27.8%
PACS Group, Inc.
$8B · P/E 27.3x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for ALKS, with each firm's 90-day track record across all stocks we track. See full firm rankings →

RBC Capital - Reiterated
Outperform → Outperform 2026-11-04 Building track record
Wells Fargo - Reiterated
Overweight → Overweight 2026-11-04 Building track record
HC Wainwright & Co. - Reiterated
Neutral → Neutral 2026-11-04 31% win rate (48 calls)
RBC Capital reit
Outperform → Outperform 2026-09-22 Building track record
Baird - Reiterated
Outperform → Outperform 2026-09-22 Building track record
Needham reit
Buy → Buy 2026-09-21 20% win rate (5 calls)
JP Morgan - Reiterated
Neutral → Neutral 2026-07-29 43% win rate (7 calls)
Baird - Reiterated
Outperform → Outperform 2026-07-29 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
48
out of 100
Coverage depth
23/30
Consensus clarity
11/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →